Literature DB >> 11897798

p73 is expressed in human thymic epithelial cells.

Shingo Ichimiya1, Takashi Kojima, Hiroyuki Momota, Nobuhiko Kondo, Toshinori Ozaki, Akira Nakagawara, María Luisa Toribio, Masakatsu Imamura, Noriyuki Sato.   

Abstract

The thymus is a heterogeneous immune organ in which immature T-cells develop and eventually specialize to make certain immune responses of their own. Among various types of stromal cells in the thymus, thymic epithelial cells (TECs) have a crucially important function for presenting self-antigens and secreting cytokines to thymocytes for their maturation into T-cells. In this study we show that the p73 gene, a homologue of the tumor suppressor gene p53, was expressed in the nucleus of the human TEC in vivo and in TEC lines in vitro. Because p73 has the capacity to be a transactivator like p53, it may contribute to T-cell development in the context of TEC biology as regulated in the cell cycle and apoptosis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11897798     DOI: 10.1177/002215540205000402

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  3 in total

Review 1.  Expression of cell cycle and apoptosis regulators in thymus and thymic epithelial tumors.

Authors:  Alexandra Papoudou-Bai; Alexandra Barbouti; Vassiliki Galani; Kalliopi Stefanaki; Dimitra Rontogianni; Panagiotis Kanavaros
Journal:  Clin Exp Med       Date:  2015-03-21       Impact factor: 3.984

2.  p63 and p73 expression in extrahepatic bile duct carcinoma and their clinical significance.

Authors:  Seung-Mo Hong; Hyungjun Cho; Christopher A Moskaluk; Eunsil Yu; Alexander I Zaika
Journal:  J Mol Histol       Date:  2007-03-24       Impact factor: 3.156

3.  ΔNp63 controls a TLR3-mediated mechanism that abundantly provides thymic stromal lymphopoietin in atopic dermatitis.

Authors:  Terufumi Kubo; Ryuta Kamekura; Ayako Kumagai; Koji Kawata; Keiji Yamashita; Yukari Mitsuhashi; Takashi Kojima; Kotaro Sugimoto; Akihiro Yoneta; Yasuyuki Sumikawa; Toshiharu Yamashita; Noriyuki Sato; Tetsuo Himi; Shingo Ichimiya
Journal:  PLoS One       Date:  2014-08-29       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.